IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Catalys Pacific, LLC

Q3 2025 Holdings

Filed 2025-11-14 | 2 holdings | $351.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Mineralys Therapeutics, Inc.(MLYS)COM603170101$337.6M8,903,83896.1%
Phathom Pharmaceuticals, Inc.(PHAT)COM71722W107$13.7M1,167,1143.9%